Perry David P's Form 4 filing
Better Therapeutics, Inc. (BTTX) · filed Sep 19, 2022
- Accession no.
- 0000899243-22-031420
- Filed
- Sep 19, 2022, 6:06 AM ET
- Trade date
- Sep 15-16, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $102.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Perry David PCIK 0001105941 | Director, Officer (See Remarks), 10% Owner |
| David P. Perry 2015 TrustCIK 0001890678 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2022 | Common Stock | PPurchaseAcquired | +10,844 | $1.99 | +$21,622.94 | 62,380 | Direct | |
| Sep 16, 2022 | Common Stock | PPurchaseAcquired | +39,156 | $2.07 | +$80,974.61 | 101,536 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.